Celldex Therapeutics (CLDX) Fails to deliver data

Key failure to deliver metrics for Celldex Therapeutics:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: A$0.15 M
• Last 3 months FTD volume: A$1.27 M
• Last year FTD volume: A$1.27 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019

Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Seagen SGEN	N/A	A$7.95 M	🇺🇸 USA
Agenus AGEN	N/A	A$4.54 M	🇺🇸 USA
Emergent BioSolutions EBS	A$1.14 M	A$5.07 M	🇺🇸 USA
Amgen AMGN	A$48.74 M	A$0.23 B	🇺🇸 USA
Pfizer PFE	A$50.21 M	A$0.38 B	🇺🇸 USA
GlaxoSmithKline GSK	A$25.89 M	A$55.2 M	🇬🇧 UK
Titan Pharmaceuticals TTNP	N/A	A$0.03 M	🇺🇸 USA